Synopsis
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Click Us!
EU-WC
NDC
Jai Radhe Sales is your partner for all your sourcing needs.
Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.
Pharm-Rx is a reputed global importer and distributor of pharmaceutical active ingredients.
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION/DROPS;OPHTHALMIC - 0.02675%...DOSAGE - SOLUTION/DROPS;OPHTHALMIC - 0.02675%;0.315%
USFDA APPLICATION NUMBER - 20065
DOSAGE - SOLUTION/DROPS;OPHTHALMIC - 0.025%;0...DOSAGE - SOLUTION/DROPS;OPHTHALMIC - 0.025%;0.3%
USFDA APPLICATION NUMBER - 20485
Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Symrise
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Coating Systems & Additives
Solubilizers
Controlled & Modified Release
Parenteral
Thickeners and Stabilizers
Taste Masking
Film Formers & Plasticizers
API Stability Enhancers
Emulsifying Agents
Topical
Rheology Modifiers
Empty Capsules
Fillers, Diluents & Binders
Direct Compression
Vegetarian Capsules
Surfactant & Foaming Agents
Granulation
Coloring Agents
Lubricants & Glidants
Chewable & Orodispersible Aids
Co-Processed Excipients
Disintegrants & Superdisintegrants
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
71
PharmaCompass offers a list of Naphazoline Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Naphazoline Hydrochloride manufacturer or Naphazoline Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Naphazoline Hydrochloride manufacturer or Naphazoline Hydrochloride supplier.
PharmaCompass also assists you with knowing the Naphazoline Hydrochloride API Price utilized in the formulation of products. Naphazoline Hydrochloride API Price is not always fixed or binding as the Naphazoline Hydrochloride Price is obtained through a variety of data sources. The Naphazoline Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Clera hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clera hydrochloride, including repackagers and relabelers. The FDA regulates Clera hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clera hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clera hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clera hydrochloride supplier is an individual or a company that provides Clera hydrochloride active pharmaceutical ingredient (API) or Clera hydrochloride finished formulations upon request. The Clera hydrochloride suppliers may include Clera hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Clera hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clera hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Clera hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Clera hydrochloride DMFs exist exist since differing nations have different regulations, such as Clera hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clera hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Clera hydrochloride USDMF includes data on Clera hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clera hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Clera hydrochloride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clera hydrochloride Drug Master File in Korea (Clera hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clera hydrochloride. The MFDS reviews the Clera hydrochloride KDMF as part of the drug registration process and uses the information provided in the Clera hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clera hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clera hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clera hydrochloride suppliers with KDMF on PharmaCompass.
A Clera hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Clera hydrochloride Certificate of Suitability (COS). The purpose of a Clera hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Clera hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Clera hydrochloride to their clients by showing that a Clera hydrochloride CEP has been issued for it. The manufacturer submits a Clera hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Clera hydrochloride CEP holder for the record. Additionally, the data presented in the Clera hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Clera hydrochloride DMF.
A Clera hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Clera hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Clera hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Clera hydrochloride written confirmation (Clera hydrochloride WC) is an official document issued by a regulatory agency to a Clera hydrochloride manufacturer, verifying that the manufacturing facility of a Clera hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clera hydrochloride APIs or Clera hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Clera hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Clera hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clera hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clera hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clera hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clera hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clera hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clera hydrochloride suppliers with NDC on PharmaCompass.
Clera hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clera hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clera hydrochloride GMP manufacturer or Clera hydrochloride GMP API supplier for your needs.
A Clera hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Clera hydrochloride's compliance with Clera hydrochloride specifications and serves as a tool for batch-level quality control.
Clera hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Clera hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clera hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Clera hydrochloride EP), Clera hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clera hydrochloride USP).
